Difficulty: Medium
Average Score: 67%
Practice
This drug increases lipoprotein lipase (LPL) activity in adipose tissue:
Correct answer
D
Rationale
In this question, the correct answer is D) Gemfibrozil (Lopid), which increases lipoprotein lipase (LPL) activity in adipose tissue.
Gemfibrozil is a fibric acid derivative that works by activating peroxisome proliferator-activated receptor-alpha (PPAR-alpha), leading to an increase in the synthesis of LPL. LPL is an enzyme that plays a key role in the breakdown of triglyceride-rich lipoproteins, thereby reducing plasma triglyceride levels.
Now, let's analyze why the other options are incorrect:
A) Cholestyramine (Questran): Cholestyramine is a bile acid sequestrant that works in the intestines by binding bile acids, not by increasing LPL activity in adipose tissue.
B) Lovastatin (Mevacor): Lovastatin is a statin that works by inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. It does not directly affect LPL activity.
C) Nicotinic acid (Niacin): Nicotinic acid primarily works by reducing the production of VLDL in the liver, not by increasing LPL activity in adipose tissue.
In an educational context, understanding the mechanisms of action of different pharmacological agents is crucial for healthcare professionals to make informed decisions when prescribing medications. Knowing how each drug affects specific pathways in the body helps in selecting the most appropriate treatment for patients based on their individual needs and conditions. This knowledge also aids in predicting potential drug interactions and adverse effects, promoting safe and effective pharmacological treatment across the lifespan.
Gemfibrozil is a fibric acid derivative that works by activating peroxisome proliferator-activated receptor-alpha (PPAR-alpha), leading to an increase in the synthesis of LPL. LPL is an enzyme that plays a key role in the breakdown of triglyceride-rich lipoproteins, thereby reducing plasma triglyceride levels.
Now, let's analyze why the other options are incorrect:
A) Cholestyramine (Questran): Cholestyramine is a bile acid sequestrant that works in the intestines by binding bile acids, not by increasing LPL activity in adipose tissue.
B) Lovastatin (Mevacor): Lovastatin is a statin that works by inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. It does not directly affect LPL activity.
C) Nicotinic acid (Niacin): Nicotinic acid primarily works by reducing the production of VLDL in the liver, not by increasing LPL activity in adipose tissue.
In an educational context, understanding the mechanisms of action of different pharmacological agents is crucial for healthcare professionals to make informed decisions when prescribing medications. Knowing how each drug affects specific pathways in the body helps in selecting the most appropriate treatment for patients based on their individual needs and conditions. This knowledge also aids in predicting potential drug interactions and adverse effects, promoting safe and effective pharmacological treatment across the lifespan.